工具变量校正剂量滴定偏倚:GENDEP试验中抗抑郁药剂量与缓解时间的剂量反应估计
该研究基于GENDEP试验380例接受艾司西酞普兰或去甲替林治疗12周的重度抑郁症患者,将随机化治疗作为工具变量,结合阈值回归与比例风险模型估计抗抑郁药剂量对缓解时间的因果效应。朴素模型中平均日剂量与缓解时间无关,而工具变量分析显示剂量增加与更快缓解显著相关。
要点
- 剂量滴定会混淆剂量与缓解时间的关联,工具变量分析可减少该偏倚。
- 工具变量阈值回归显示剂量增加与更快缓解显著相关(速度估计0.878,95%CI 0.152-1.603)。
- 工具变量比例风险模型同样显示剂量增加与更快缓解相关(对数风险比3.012,95%CI 0.086-5.938)。
核心结论
- 工具变量分析比朴素关联分析更能提供抗抑郁药剂量对缓解时间影响的合理因果估计。
- GENDEP试验数据支持抗抑郁药剂量增加与抑郁缓解时间缩短之间的关联。
研究设计与样本
- 基于GENDEP试验的临床 trial 数据二次分析,纳入380名接受艾司西酞普兰或去甲替林治疗12周的重度抑郁症患者。
- 每周测量抗抑郁药剂量,计算12周内相对于最大处方剂量的平均剂量。
- 将随机化治疗作为工具变量,结合阈值回归与比例风险生存模型进行分析。
主要发现
- 朴素模型中平均日剂量与缓解时间缩短无关。
- 工具变量阈值回归显示剂量增加与更快缓解显著相关,速度估计0.878(95%CI 0.152-1.603)。
- 工具变量比例风险模型显示剂量增加与更快缓解相关,对数风险比3.012(95%CI 0.086-5.938)。
- 阈值回归模型更清晰地区分与初始严重度相关的因素和影响治疗效应的因素。
临床怎么用
- 在存在剂量滴定的抗抑郁药治疗中,评估剂量效应时应考虑工具变量方法以减少混杂偏倚。
- 阈值回归可用于区分与初始严重度相关的因素和影响治疗效应的因素。
局限性
- 工具变量分析结果的有效性取决于是否满足工具变量分析假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Threshold regression, in which time to remission is modelled as a stochastic drift towards a boundary, is an alternative to the proportional hazards survival model and has a clear conceptual mechanism for examining the effects of drug dose. However, for both threshold regression and proportional hazard models, when dose titration occurs during treatment, the estimated causal effect of dose can be biased by confounding. An instrumental variable analysis can be used to minimise such bias. METHOD: Weekly antidepressant dose was measured in 380 men and women with major depression treated with escitalopram or nortriptyline for 12 weeks as part of the Genome Based Therapeutic Drugs for Depression (GENDEP) study. The averaged dose relative to maximum prescribing dose was calculated from the 12 trial weeks and tested for association with time to depression remission. We combined the instrumental variable approach, utilising randomised treatment as an instrument, with threshold regression and proportional hazard survival models. RESULTS: The threshold model was constructed with two linear predictors. In the naïve models, averaged daily dose was not associated with reduced time to remission. By contrast, the instrumental variable analyses showed a clear and significant relationship between increased dose and faster time to remission, threshold regression (velocity estimate: 0.878, 95% confidence interval [CI]: 0.152-1.603) and proportional hazards (log hazards ratio: 3.012, 95% CI: 0.086-5.938). CONCLUSIONS: We demonstrate, using the GENDEP trial, the benefits of these analyses to estimate causal parameters rather than those that estimate associations. The results for the trial dataset show the link between antidepressant dose and time to depression remission. The threshold regression model more clearly distinguishes the factors associated with initial severity from those influencing treatment effect. Additionally, applying the instrumental variable estimator provides a more plausible causal estimate of drug dose on treatment effect. This validity of these results is subject to meeting the assumptions of instrumental variable analyses. TRIAL REGISTRATION: EudraCT, 2004-001723-38; ISRCTN, 03693000. Registered on 27 September 2007.
引用
- Hellier J, Emsley R, Pickles A, et al. Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data. Trials. 2020. PMID: 31900198. doi:10.1186/s13063-019-3810-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。